Correction: Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure with mifepristone-misoprostol regimens: a retrospective cohort study - Scorecard - MDSpire

Correction: Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure with mifepristone-misoprostol regimens: a retrospective cohort study

  • By

  • Rui-Hong Xue

  • Juan Li

  • Yun-Xia Li

  • Zhao-Ying Gu

  • Dan Tang

  • Jing Yang

  • Yan-Yan Fu

  • Xin-Liang Chen

  • Ping Liu

  • July 13, 2026

Share

Clinical Scorecard: Correction: The Role of Ultrasound-Determined Gestational Sac Triple Product in Predicting Early Medical Abortion Failure with Mifepristone-Misoprostol: A Retrospective Cohort Analysis

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Correction
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingSpecify the type of clinical settings.

Key Highlights

  • highlight_1

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Women undergoing early medical abortion with mifepristone-misoprostol

          Ultrasound assessment may aid in predicting abortion failure

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content